Sobetirome (GMP) is Sobetirome (HY-14823) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Sobetirome (GC-1) is a thyroid hormone receptor β (TRβ)-specific agonist which bind selectively to TRβ-1 with an EC50 of 0.16 μM.
For research use only. We do not sell to patients.
- CAS No.: 211110-63-3
- Formula: C20H24O4
- Molecular Weight:328.40
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-14823
SobetiromeTRβ Agonist -
HY-12216
ResmetiromTHR-β Agonist -
HY-A0070
Liothyronine sodiumTRα/TRβ Agonist -
HY-14823R
Sobetirome (Standard)TRβ Agonist -
HY-W010696
Reverse T3Thyroid Hormone -
HY-A0070R
Liothyronine sodium (Standard)TRα/TRβ Agonist -
HY-W010696R
Reverse T3 (Standard)Thyroid Hormone -
HY-B0208
MethimazoleAnti-thyroid Agent -
HY-18341A
L-Thyroxine sodium salt pentahydrateThyroid Hormone -
HY-B1201
TiratricolThyroid Hormone Receptor Inhibitor -
HY-127024
Thyroid hormone receptor antagonist (1-850)TR Antagonist -
HY-111288
MB-07811
Biological Activity
Description
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 211110-63-3
-
Molecular Weight 328.40
-
Formula C20H24O4
-
SMILES
O=C(O)COC1=CC(C)=C(CC2=CC=C(O)C(C(C)C)=C2)C(C)=C1
-
Synonyms
GC-1 (GMP); QRX-431 (GMP)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Endocrine Diseases
Endocrine diseases often arise from disrupted hormone production, hormone signaling, or target-tissue responsiveness; for diabetes-focused endocrine disease models, insulin signaling regulates glucose uptake, hepatic glucose output, lipid metabolism, and β-cell compensation. Type 2 diabetes develops through interacting defects in insulin resistance, β-cell dysfunction, adipose inflammation, hepatic glucose overproduction, altered incretin signaling, and ectopic lipid metabolism. A major unresolved question is whether endocrine dysfunction is driven primarily by target-tissue insulin resistance, intrinsic β-cell failure, immune/inflammatory stress, or combined multi-organ failure that differs by disease stage.
Purity & Documentation
References
[1]. Gierach I, et al. Bacterial biosensors for screening isoform-selective ligands for human thyroid receptors α-1 and β-1. FEBS Open Bio. 2012 Aug 15;2:247-53. [Content Brief]
[2]. Johansson L, et al. Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice. Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10297-302. [Content Brief]
[3]. Villicev CM, et al. Thyroid hormone receptor beta-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats. J Endocrinol. 2007 Apr;193(1):21-9. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Sobetirome (GMP) Related Classifications
HY-14823G Related Classifications
Powered by Bioz